Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 2 |
2016 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for
carlos morera beta
Your search for
Carlos Morera Beita
retrieved no results
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline.
Alzheimers Res Ther. 2023 Jan 5;15(1):2. doi: 10.1186/s13195-022-01143-z.
Alzheimers Res Ther. 2023.
PMID: 36604729
Free PMC article.
In this study, we investigated the ability of plasma amyloid-beta (Abeta)42/Abeta40 ratio measured by an antibody-free mass-spectrometric (MS) method, ABtest-MS, to detect early pathological changes of AD. ...
In this study, we investigated the ability of plasma amyloid-beta (Abeta)42/Abeta40 ratio measured by an antibody-free mass-spectrome …
Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.
Alonso N, Miró E, Pascual V, Rivera A, Simó M, Garcia MC, Xercavins M, Morera MA, Espejo E, Gurguí M, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E, Navarro F, Mirelis B, Coll P.
Alonso N, et al.
Int J Antimicrob Agents. 2016 Jan;47(1):62-8. doi: 10.1016/j.ijantimicag.2015.10.007. Epub 2015 Nov 2.
Int J Antimicrob Agents. 2016.
PMID: 26607336
IncI1 and IncF plasmids were also analysed by plasmid MLST and replicon sequence typing, respectively. Among 21563 E. coli isolates, 240 (1.1%) overproduced AmpC beta-lactamases, including 180 (75.0%) harbouring ac-AmpC (132 CMY-2 variants and 48 DHA-1) and 60 (25.0%) c-Am …
IncI1 and IncF plasmids were also analysed by plasmid MLST and replicon sequence typing, respectively. Among 21563 E. coli isolates, 240 (1. …
Item in Clipboard
Epidemiology and risk factors for infections due to AmpC beta-lactamase-producing Escherichia coli.
Pascual V, Ortiz G, Simó M, Alonso N, Garcia MC, Xercavins M, Rivera A, Morera MA, Miró E, Espejo E, Navarro F, Gurguí M, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E.
Pascual V, et al.
J Antimicrob Chemother. 2015 Mar;70(3):899-904. doi: 10.1093/jac/dku468. Epub 2014 Dec 2.
J Antimicrob Chemother. 2015.
PMID: 25468902
OBJECTIVES: To describe the prevalence and risk factors for infection due to AmpC beta-lactamase-producing Escherichia coli (AmpC-EC). METHODS: For the prevalence study, all clinical isolates of E. coli with reduced susceptibility to third-generation cephalosporins were pr …
OBJECTIVES: To describe the prevalence and risk factors for infection due to AmpC beta-lactamase-producing Escherichia coli (AmpC-EC) …
Item in Clipboard
Bloodstream infections caused by Escherichia coli producing AmpC beta-lactamases: epidemiology and clinical features.
Pascual V, Alonso N, Simó M, Ortiz G, Garcia MC, Xercavins M, Rivera A, Morera MA, Miró E, Espejo E, Navarro F, Gurguí M, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E.
Pascual V, et al.
Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):1997-2003. doi: 10.1007/s10096-016-2752-3. Epub 2016 Aug 22.
Eur J Clin Microbiol Infect Dis. 2016.
PMID: 27549108
The aim of the study was to investigate the epidemiology and clinical features of bloodstream infections due to Escherichia coli producing AmpC beta-lactamases (AmpC-Ec-BSI). In a multi-centre case-control study, all third-generation-cephalosporin-resistant Escherichia col …
The aim of the study was to investigate the epidemiology and clinical features of bloodstream infections due to Escherichia coli producing A …
Item in Clipboard
Cite
Cite